VIARTIS
|
||
|
PARKINSON'S DISEASE NEWS
|
|
26th November 2009 - New research DOPAMINERGIC TRANSPLANTS FAIL IN PARKINSON'S DISEASE Annals of Neurology [2009] 66
(5) : 591-596 (Olanow CW, Kordower JH, Lang AE, Obeso JA.)
Complete abstract In addition, disability in advanced patients primarily results from features that are not primarily due to insufficient dopamine. These features are not adequately controlled with dopaminergic therapies and are thus unable to respond to dopaminergic transplants. Implanted dopaminergic neurons have also recently been found to contain Lewy bodies, which are signs of cell damage, suggesting that even after transplantation they are dysfunctional and may have been affected by the Parkinson's Disease process. Although stem cell therapies have been tried in Parkinson's Disease based on the claim that there is a massive loss of dopamine producing cells in Parkinson's Disease, not a single study has ever shown this to be true. For more current news go to Parkinson's Disease News.
E-MAIL NOTIFICATION : If you would like to be notified by e-mail when any new research, news reports, new books, or new resources are added to Parkinson's Disease News, please double click on E-MAIL NOTIFICATION, or e-mail [email protected]. No form of identity is required. E-mail addresses are not used for any other purpose. Parkinson's Disease News details all significant new research, news reports, new books, and new resources concerning Parkinson's Disease and those medical disorders that often coincide with Parkinson's Disease. It is compiled from an analysis of all newly published research, news reports, new clinical trials, all newly published books, and new web sites. A summary and analysis of the new research are provided, as well as links to the complete abstracts and news reports.
|
||
|
||
©2006-2009 Viartis | ||
2015-11-10 13:13:15 | ||
[email protected] |